{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:11:43Z","timestamp":1757589103621},"reference-count":38,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T00:00:00Z","timestamp":1236643200000},"content-version":"unspecified","delay-in-days":7465,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Technol Assess Health Care"],"published-print":{"date-parts":[[1988,10]]},"abstract":"<jats:p>The evaluation of innovations which use old technology poses different problems than does the evaluation of new technologies. The main necessity is the targeting of its use rather than the technology itself. The need to evaluate the extent of use and its problems is illustrated by the example of progestin use among menopausal and postmenopausal women in the United States. There progestins are not of ficially approved for use in menopause, even though they have been on the market for a long time with other indications. Estrogen-replacement therapy was widely used from the early 1960s until 1975, when the claim that estrogens cause endometrial cancer notably decreased their use. The use of estrogens increased again in the early 1980s, and one reason for this revival was the claim that progestins offered protection against endometrial cancer. When recommendations for combined estrogen-progestin therapy have been made, other health effects have been ignored. Two consensus conferences as well as the drug control authority have recommended against combined estrogen-progestin therapy until further research is completed. Absence of good research, specialization in medicine, and advantages for prescribers and the drug industry may have contributed to the wide use of this unassessed treatment. Possible solutions for prevention of the diffusion of these kinds of innovations are discussed.<\/jats:p>","DOI":"10.1017\/s0266462300007595","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T08:15:45Z","timestamp":1236672945000},"page":"511-519","source":"Crossref","is-referenced-by-count":10,"title":["The Use of Combined Estrogen-Progestin Replacement Therapy: An Example of the Dissemination of New Indications for an Old Technology"],"prefix":"10.1017","volume":"4","author":[{"given":"Elina","family":"Hemminki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2009,3,10]]},"reference":[{"key":"S0266462300007595_ref020","first-page":"113","volume-title":"Women, health and healing","author":"Kaufert","year":"1985"},{"key":"S0266462300007595_ref015","unstructured":"15. Hemminki E. , Kennedy D. L. , Baum C. , & McKinlay S. Prescribing of noncontraceptive estrogens and progestins in the United States 1974\u20131986. American Journal of Public Health, in press."},{"key":"S0266462300007595_ref032","doi-asserted-by":"publisher","DOI":"10.3109\/00016348509157149"},{"key":"S0266462300007595_ref016","unstructured":"16. Hemminki E. , Brambilla D. , McKinlay S. M. , & McKinlay J. B. Use of estrogens among mid-aged Massachusetts women. Unpublished."},{"key":"S0266462300007595_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(86)90022-8"},{"key":"S0266462300007595_ref030","first-page":"424","article-title":"Prescribing estrogens during menopause: Physician survey of practices in 1974 and 1981","volume":"99","author":"Pasley","year":"1984","journal-title":"Public Health Report"},{"key":"S0266462300007595_ref017","doi-asserted-by":"publisher","DOI":"10.1177\/002204268801800210"},{"key":"S0266462300007595_ref004","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036287"},{"key":"S0266462300007595_ref013","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(79)90289-8"},{"key":"S0266462300007595_ref027","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780020222"},{"key":"S0266462300007595_ref029","volume-title":"Consensus development conference statement: Osteoporosis. April 2\u20134","year":"1984"},{"key":"S0266462300007595_ref014","first-page":"57","article-title":"Oestrogen therapy in the pen-menopause: A practical approach","volume":"233","author":"Haspels","year":"1980","journal-title":"Acta Endocrinologica"},{"key":"S0266462300007595_ref038","doi-asserted-by":"crossref","unstructured":"38. World Health Organization. World Health Statistics Annual 1986. Geneva: WHO, 1986, 256\u201360","DOI":"10.2307\/2531574"},{"key":"S0266462300007595_ref001","unstructured":"1. American College of Gynecology and Obstetrics. Estrogen replacement therapy. ACOG Technical Bulletin, No. 93, 1986."},{"key":"S0266462300007595_ref003","first-page":"620","article-title":"Postmenopausal estrogen\u2013current prescribing patterns of San Diego gynecologists","volume":"144","author":"Barrett-Connor","year":"1986","journal-title":"Western Journal of Medicine"},{"key":"S0266462300007595_ref005","first-page":"204","article-title":"Informed consent, clinical research and the practice of medicine","volume":"94","author":"Chalmers","year":"1982","journal-title":"Transactions of the American Clinical and Climatological Association"},{"key":"S0266462300007595_ref012","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM197904193001613","article-title":"Estrogen use and endometrial cancer","volume":"300","author":"Greenblatt","year":"1979","journal-title":"New England Journal of Medicine"},{"key":"S0266462300007595_ref006","first-page":"107","article-title":"Osteoporosis","volume":"32","author":"Davies","year":"1985","journal-title":"American Family Physician"},{"key":"S0266462300007595_ref007","first-page":"715","article-title":"Progesterone and breast cancer","volume":"68","author":"Ernster","year":"1986","journal-title":"Obstetrics and Gynecology"},{"key":"S0266462300007595_ref008","unstructured":"8. Food and Drug Administration. Estrogens for osteoporosis. FDA Drug Bulletin, 1986, 06 5\u20136."},{"key":"S0266462300007595_ref009","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0015-0282(16)46149-2","article-title":"The menopause: Benefits and risks of estrogen-progestogen replacement therapy","volume":"37","author":"Gambrell","year":"1982","journal-title":"Fertility and Sterility"},{"key":"S0266462300007595_ref011","first-page":"851","article-title":"Estrogen use and postmenopausal women: A basis for informed decisions","volume":"11","author":"Gastel","year":"1980","journal-title":"Journal of Family Practice"},{"key":"S0266462300007595_ref026","first-page":"197","volume-title":"Coronary heart disease in young women","author":"McMahon","year":"1978"},{"key":"S0266462300007595_ref018","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90306-2"},{"key":"S0266462300007595_ref019","first-page":"267","article-title":"Estrogen replacement therapy","volume":"58","author":"Judd","year":"1981","journal-title":"Obstetrics and Gynecology"},{"key":"S0266462300007595_ref021","first-page":"27","article-title":"Prescribing FDA-approved drugs in nonapproved ways","volume":"22","author":"Kaunitz","year":"1983","journal-title":"Contetnporary Obstetrics and Gynecology"},{"key":"S0266462300007595_ref022","volume-title":"Gynecology. Principles and practice","author":"Kistner","year":"1964"},{"key":"S0266462300007595_ref023","first-page":"913","article-title":"Arteriosclerosis risk. The roles of oral contraceptives and postmenopausal estrogens","volume":"31","author":"Knopp","year":"1986","journal-title":"Journal of Reproductive Medicine"},{"key":"S0266462300007595_ref024","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1982.00340190087017"},{"key":"S0266462300007595_ref025","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-009-6430-3_4"},{"key":"S0266462300007595_ref028","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-197907000-00017"},{"key":"S0266462300007595_ref031","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.280.6217.822"},{"key":"S0266462300007595_ref033","doi-asserted-by":"publisher","DOI":"10.3109\/00016348609155173"},{"key":"S0266462300007595_ref035","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90341-9"},{"key":"S0266462300007595_ref036","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91504-6"},{"key":"S0266462300007595_ref037","first-page":"71","article-title":"Therapeutic considerations in the management of the climacteric","volume":"29","author":"Upton","year":"1984","journal-title":"Journal of Reproductive Medicine"},{"key":"S0266462300007595_ref002","doi-asserted-by":"publisher","DOI":"10.1300\/J013v11n03_13"},{"key":"S0266462300007595_ref034","volume-title":"Physicians' Desk Reference 1986","year":"1986"}],"container-title":["International Journal of Technology Assessment in Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0266462300007595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T15:06:12Z","timestamp":1558364772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0266462300007595\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1988,10]]}},"alternative-id":["S0266462300007595"],"URL":"https:\/\/doi.org\/10.1017\/s0266462300007595","relation":{},"ISSN":["0266-4623","1471-6348"],"issn-type":[{"value":"0266-4623","type":"print"},{"value":"1471-6348","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,10]]}}}